BioLine RX Ltd (BLRX) — Strategic Asset Allocation Index
BioLine RX Ltd (BLRX) has a Strategic Asset Allocation Index of 10.6% as of June 2023. Strategic assets (PP&E of ILA2.23 Million plus long-term investments of ILA-) total ILA2.23 Million, measured against net assets of ILA21.05 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BLRX net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
BioLine RX Ltd Strategic Asset Allocation Index (2005–2021)
This chart shows how BioLine RX Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2005 to 2021. As of June 2023, the index stands at 10.6%, representing strategic assets of ILA2.23 Million against net assets of ILA21.05 Million ILA. For live market cap and overall valuation, see how much is BioLine RX Ltd worth.
Annual Strategic Asset Allocation Index for BioLine RX Ltd (2005–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for BioLine RX Ltd from 2005 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of BioLine RX Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.4% | ILA2.28 Million | ILA2.28 Million | ILA- | ILA68.09 Million | ▼ -8.9 pp |
| 2020 | 12.2% | ILA2.70 Million | ILA2.70 Million | ILA- | ILA22.03 Million | ▲ +1.9 pp |
| 2019 | 10.4% | ILA3.47 Million | ILA3.47 Million | ILA- | ILA33.38 Million | ▲ +5.0 pp |
| 2018 | 5.4% | ILA2.23 Million | ILA2.23 Million | ILA0.00 | ILA41.32 Million | ▼ -1.2 pp |
| 2017 | 6.6% | ILA3.50 Million | ILA2.50 Million | ILA1.00 Million | ILA52.88 Million | ▼ -0.8 pp |
| 2016 | 7.4% | ILA2.60 Million | ILA2.60 Million | ILA- | ILA35.03 Million | ▲ +1.3 pp |
| 2015 | 6.1% | ILA2.91 Million | ILA2.91 Million | ILA- | ILA47.61 Million | ▼ -2.7 pp |
| 2014 | 8.8% | ILA2.80 Million | ILA2.80 Million | ILA- | ILA31.77 Million | ▼ -12.3 pp |
| 2013 | 21.2% | ILA2.47 Million | ILA2.47 Million | ILA- | ILA11.68 Million | ▼ 0.0 pp |
| 2012 | 21.2% | ILA3.17 Million | ILA3.17 Million | ILA- | ILA14.97 Million | ▲ +2.5 pp |
| 2011 | 18.7% | ILA4.21 Million | ILA4.21 Million | ILA- | ILA22.53 Million | ▲ +15.3 pp |
| 2010 | 3.4% | ILA4.51 Million | ILA4.51 Million | ILA- | ILA131.96 Million | ▼ -0.1 pp |
| 2009 | 3.5% | ILA4.17 Million | ILA4.17 Million | ILA- | ILA117.94 Million | ▼ -3.5 pp |
| 2008 | 7.0% | ILA5.48 Million | ILA5.48 Million | ILA- | ILA78.39 Million | ▲ +5.0 pp |
| 2007 | 2.0% | ILA3.73 Million | ILA3.73 Million | ILA- | ILA183.25 Million | ▼ -15.3 pp |
| 2005 | 17.3% | ILA2.21 Million | ILA2.21 Million | ILA- | ILA12.77 Million | — |